PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 144 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $111,260 | -36.8% | 10,198 | -51.2% | 0.01% | -7.1% |
Q3 2022 | $176,000 | -83.9% | 20,887 | -84.9% | 0.01% | -84.4% |
Q2 2022 | $1,095,000 | +98.0% | 138,395 | +492.4% | 0.09% | +95.7% |
Q1 2022 | $553,000 | +30.7% | 23,360 | -2.2% | 0.05% | -9.8% |
Q3 2021 | $423,000 | – | 23,876 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |